Targeting inflammation to improve regulatory T cell therapy for immunopathologies
Sign Up to like & getrecommendations! Published in 2022 at "Proceedings of the National Academy of Sciences of the United States of America"
DOI: 10.1073/pnas.2215271119
Abstract: Inflammation is a normal, transient physiological defense against infectious diseases. However, in many chronic conditions such as autoimmune diseases (AIDs) or graft rejections, the inflammatory response lingers on, leading to significant damage. Long-term immunosuppressive treatments… read more here.
Keywords: inflammation; targeting inflammation; inflammation improve; cell therapy ... See more keywords